An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
Public ClinicalTrials.gov record NCT03692897. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The TARGET-HBV study engages an observational research design to conduct a comprehensive review of outcomes for patients with CHB infection. The initial phase of the study that enrolled patients treated with tenofovir alafenamide (TAF) was successfully completed. The current protocol (Amendment 1) describes the second phase of the study that will engage research activities for patients being managed for CHB in usual clinical practice in the US and Canada. The study addresses important clinical questions regarding the management of CHB by collecting and analyzing data from patients at academic and community medical centers. TARGET-HBV creates a robust database of real-world data regarding the natural history, management, and health outcomes related to antiviral treatments used in clinical practice.
Study identification
- NCT ID
- NCT03692897
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,708 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2018 (Actual)
- Primary completion
- Sep 10, 2025 (Actual)
- Completion
- Sep 10, 2025 (Actual)
- Last update posted
- Sep 17, 2025
2018 – 2025
United States locations
- U.S. sites
- 30
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University Medical Center Phoenix | Phoenix | Arizona | 85006 | — |
| Asian Pacific Liver Center at Coalition of Inclusive Medicine | Los Angeles | California | 90020 | — |
| California Liver Research Institute | Pasadena | California | 91105 | — |
| Stanford University | Redwood City | California | 94063 | — |
| UC Davis GI/Hepatology Clinical Trials Unit | Sacramento | California | 95817 | — |
| Silicon Valley Research Institute | San Jose | California | 95128 | — |
| Yale University Digestive Diseases | New Haven | Connecticut | 06520 | — |
| Medstar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| University of Florida | Gainesville | Florida | 32610-0272 | — |
| University of Miami, Schiff Center for Liver Disease | Miami | Florida | 33136 | — |
| Consultative Gastroenterology | Atlanta | Georgia | 30308 | — |
| Atlanta Gastroenterology | Atlanta | Georgia | 30342 | — |
| Rush Universtiy Medical Center | Chicago | Illinois | 60612 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Mercy Medical Center | Baltimore | Maryland | 21202 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| Minnesota Gastroenterology, P.A. | Plymouth | Minnesota | 55446 | — |
| Rutgers, Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| Dreamwork Medical, PLLC | Flushing | New York | 11354 | — |
| Northwell Health Center for Liver Diseases and Transplantation | Manhasset | New York | 11030 | — |
| NYU Langone Health | New York | New York | 10016 | — |
| Weill Cornell Medical College | New York | New York | 10021 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| UNC Liver Center | Chapel Hill | North Carolina | 27599 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Digestive and Liver Disease Specialist | Norfolk | Virginia | 23502 | — |
| Bon Secours Liver Institute of Richmond | Richmond | Virginia | 23226 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Swedish Organ Transplant and Liver Center | Seattle | Washington | 98104 | — |
| University of Washington/Harborview Medical Center | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03692897, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 17, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03692897 live on ClinicalTrials.gov.